Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Entero Healthcare Solutions Limited (NSE: ENTERO), ISIN INE010601016 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
ENTERO last traded at ₹2084.90 (+9.71%), with a 52-week range of ₹944.00 to ₹2083.10 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 52.40%, FIIs 5.76%, DIIs 21.16%, mutual funds 11.15%.
EquiSense Score (ECS): 65/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.